EPAS1 and paraganglioma: Herein, we investigated mutations in EPAS1 in a cohort of phaeochromocytoma (n = 57) or paraganglioma (n = 14) and have described the clinical, molecular and genetic features of patients carrying somatic EPAS1 mutations.